Pharmafile Logo
Pharmafocus logo
Advanced Search

Xeloda

Showing 12 posts of 12 posts found.

Roche image

Roche dealt with two late-stage blows

December 19, 2014
Sales and Marketing Alzheimer's, Alzheimer’s, Cancer, Kadcyla, Perjeta, Roche, Xeloda, trastuzumab emtansine

Swiss giant Roche’s breast cancer treatment Kadcyla has failed to meet its primary endpoint and its investigational Alzheimer’s treatment trial …

News

Eisai restates Halaven’s challenge to Roche’s Xeloda

September 30, 2013
Research and Development, Sales and Marketing ECC, Halaven, Roche, Xeloda

Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …

News

Novartis/Incyte’s Jakavi may help fight pancreatic cancer

August 22, 2013
Research and Development, Sales and Marketing Incyte, Jakafi, Novartis, Pancreatic cancer, Xeloda

News
Tyvber image

GSK and Roche get EU breast cancer indication

August 15, 2013
Sales and Marketing GSK, Herceptin, Roche, Tyverb, Xeloda, breast cancer

The European Commission has granted a new indication for the use of GSK’s breast cancer drug Tyverb in combination with …

News
Roche image

Roche to submit Herceptin successor to regulators

April 2, 2012
Research and Development, Sales and Marketing GSK, Herceptin, Roche, Xeloda

Roche has said it will submit its new breast cancer drug trastuzumab for regulatory review in the US and Europe …

News
Tyverb picture

GSK pulls Tyverb extension in Europe

February 17, 2012
Sales and Marketing GSK, Herceptin, Tyverb, Xeloda

GlaxoSmithKline has withdrawn its European application to extend the licence of its breast cancer pill Tyverb. The firm was seeking …

News

FDA approves Eisai breast cancer drug Halaven

November 16, 2010
Sales and Marketing Cancer, Eisai, FDA, Halaven, Xeloda, breast cancer, eribulin mesylate, metastatic breast cancer

The FDA has approved Eisai’s advanced breast cancer drug Halaven for use in heavily pre-treated breast cancer patients. Halaven (eribulin …

News
Iressa

NICE approves trio of cancer drugs

July 28, 2010
Sales and Marketing Iressa, MabThera, NICE, Xeloda

NICE has given its final recommendation to a trio of drugs for the treatment of various cancers, which means the …

News

Eisai’s breast cancer drug impresses at ASCO

June 9, 2010
Research and Development ASCO, Eisai, Xeloda, eribulin

A new cancer drug developed by Japanese pharma company Eisai has shown promise in increasing overall survival rates in heavily …

News

Xeloda for gastric cancer gains NICE nod

June 2, 2010
Sales and Marketing UK, Xeloda

NICE has recommended Roche’s Xeloda as a first line treatment of inoperable advanced gastric cancer.The cost-effectiveness body says the oral …

News

Roche’s Xeloda widens licence

April 1, 2010
Sales and Marketing Cancer, Roche, Xeloda, colorectal cancer

Roche’s oral chemotherapy drug Xeloda has been approved in Europe in combination with intravenous oxaliplatin for the treatment of patients …

News

Roche eyes expanded colon cancer label for Xeloda

July 20, 2009
Research and Development, Sales and Marketing Roche, Xeloda

Roche is set to expand Xeloda's colon cancer indication, after a new combination of the drug was shown to increase …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025